161 related articles for article (PubMed ID: 38658630)
21. Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes.
Huang C; Cintra M; Brennan K; Zhou M; Colevas AD; Fischbein N; Zhu S; Gevaert O
EBioMedicine; 2019 Jul; 45():70-80. PubMed ID: 31255659
[TBL] [Abstract][Full Text] [Related]
22. Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive.
Zhu Y; Mohamed ASR; Lai SY; Yang S; Kanwar A; Wei L; Kamal M; Sengupta S; Elhalawani H; Skinner H; Mackin DS; Shiao J; Messer J; Wong A; Ding Y; Zhang L; Court L; Ji Y; Fuller CD
JCO Clin Cancer Inform; 2019 Feb; 3():1-9. PubMed ID: 30730765
[TBL] [Abstract][Full Text] [Related]
23. Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma.
Bogowicz M; Riesterer O; Stark LS; Studer G; Unkelbach J; Guckenberger M; Tanadini-Lang S
Acta Oncol; 2017 Nov; 56(11):1531-1536. PubMed ID: 28820287
[TBL] [Abstract][Full Text] [Related]
24. A radiomics model to predict γδ T-cell abundance and overall survival in head and neck squamous cell carcinoma.
Fan B; Fan B; Sun N; Zou H; Gu X
FASEB J; 2024 Mar; 38(5):e23529. PubMed ID: 38441524
[TBL] [Abstract][Full Text] [Related]
25. Radiomics for therapy-specific head and neck squamous cell carcinoma survival prognostication (part I).
Bernatz S; Böth I; Ackermann J; Burck I; Mahmoudi S; Lenga L; Martin SS; Scholtz JE; Koch V; Grünewald LD; Koch I; Stöver T; Wild PJ; Winkelmann R; Vogl TJ; Dos Santos DP
BMC Med Imaging; 2023 Jun; 23(1):71. PubMed ID: 37268876
[TBL] [Abstract][Full Text] [Related]
26. Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma.
Bogowicz M; Riesterer O; Ikenberg K; Stieb S; Moch H; Studer G; Guckenberger M; Tanadini-Lang S
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):921-928. PubMed ID: 28807534
[TBL] [Abstract][Full Text] [Related]
27. [Advances in head and neck squamous cell cancer research based on radiomics].
Dong Y; Zhang A; Zhang J; Liu L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Feb; 35(2):181-184. PubMed ID: 33541006
[No Abstract] [Full Text] [Related]
28. Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status.
Ou D; Blanchard P; Rosellini S; Levy A; Nguyen F; Leijenaar RTH; Garberis I; Gorphe P; Bidault F; Ferté C; Robert C; Casiraghi O; Scoazec JY; Lambin P; Temam S; Deutsch E; Tao Y
Oral Oncol; 2017 Aug; 71():150-155. PubMed ID: 28688683
[TBL] [Abstract][Full Text] [Related]
29. Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma.
Essers PBM; van der Heijden M; Vossen D; de Roest RH; Leemans CR; Brakenhoff RH; van den Brekel MWM; Bartelink H; Verheij M; Vens C
Int J Cancer; 2020 Sep; 147(6):1732-1739. PubMed ID: 32167160
[TBL] [Abstract][Full Text] [Related]
30. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.
Keek S; Sanduleanu S; Wesseling F; de Roest R; van den Brekel M; van der Heijden M; Vens C; Giuseppina C; Licitra L; Scheckenbach K; Vergeer M; Leemans CR; Brakenhoff RH; Nauta I; Cavalieri S; Woodruff HC; Poli T; Leijenaar R; Hoebers F; Lambin P
PLoS One; 2020; 15(5):e0232639. PubMed ID: 32442178
[TBL] [Abstract][Full Text] [Related]
31. Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC.
Rabasco Meneghetti A; Zwanenburg A; Linge A; Lohaus F; Grosser M; Baretton GB; Kalinauskaite G; Tinhofer I; Guberina M; Stuschke M; Balermpas P; von der Grün J; Ganswindt U; Belka C; Peeken JC; Combs SE; Böke S; Zips D; Troost EGC; Krause M; Baumann M; Löck S
Sci Rep; 2022 Oct; 12(1):16755. PubMed ID: 36202941
[TBL] [Abstract][Full Text] [Related]
32. The role of radiomics in tongue cancer: A new tool for prognosis prediction.
Mossinelli C; Tagliabue M; Ruju F; Cammarata G; Volpe S; Raimondi S; Zaffaroni M; Isaksson JL; Garibaldi C; Cremonesi M; Corso F; Gaeta A; Emili I; Zorzi S; Alterio D; Marvaso G; Pepa M; De Fiori E; Maffini F; Preda L; Benazzo M; Jereczek-Fossa BA; Ansarin M
Head Neck; 2023 Apr; 45(4):849-861. PubMed ID: 36779382
[TBL] [Abstract][Full Text] [Related]
33. Constrast-enhanced computed tomography radiomics predicts CD27 expression and clinical prognosis in head and neck squamous cell carcinoma.
Wang F; Zhang W; Chai Y; Wang H; Liu Z; He Y
Front Immunol; 2022; 13():1015436. PubMed ID: 36458007
[TBL] [Abstract][Full Text] [Related]
34. External validation of nodal failure prediction models including radiomics in head and neck cancer.
Zhai TT; Wesseling F; Langendijk JA; Shi Z; Kalendralis P; van Dijk LV; Hoebers F; Steenbakkers RJHM; Dekker A; Wee L; Sijtsema NM
Oral Oncol; 2021 Jan; 112():105083. PubMed ID: 33189001
[TBL] [Abstract][Full Text] [Related]
35. Construction of an enhanced computed tomography radiomics model for non-invasively predicting granzyme A in head and neck squamous cell carcinoma by machine learning.
Hang R; Bai G; Sun B; Xu P; Sun X; Yan G; Zhang W; Wang F
Eur Arch Otorhinolaryngol; 2023 Jul; 280(7):3353-3364. PubMed ID: 36920557
[TBL] [Abstract][Full Text] [Related]
36. A CT-based Deep Learning Radiomics Nomogram for the Prediction of EGFR Mutation Status in Head and Neck Squamous Cell Carcinoma.
Zheng YM; Pang J; Liu ZJ; Yuan MG; Li J; Wu ZJ; Jiang Y; Dong C
Acad Radiol; 2024 Feb; 31(2):628-638. PubMed ID: 37481418
[TBL] [Abstract][Full Text] [Related]
37. Machine Learning Based Radiomic HPV Phenotyping of Oropharyngeal SCC: A Feasibility Study Using MRI.
Sohn B; Choi YS; Ahn SS; Kim H; Han K; Lee SK; Kim J
Laryngoscope; 2021 Mar; 131(3):E851-E856. PubMed ID: 33070337
[TBL] [Abstract][Full Text] [Related]
38. Development of a Model Based on Delta-Radiomic Features for the Optimization of Head and Neck Squamous Cell Carcinoma Patient Treatment.
Šedienė S; Kulakienė I; Urbonavičius BG; Korobeinikova E; Rudžianskas V; Povilonis PA; Jaselskė E; Adlienė D; Juozaitytė E
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374377
[No Abstract] [Full Text] [Related]
39. Quantitative ultrasound radiomics in predicting recurrence for patients with node-positive head-neck squamous cell carcinoma treated with radical radiotherapy.
Dasgupta A; Fatima K; DiCenzo D; Bhardwaj D; Quiaoit K; Saifuddin M; Karam I; Poon I; Husain Z; Tran WT; Sannachi L; Czarnota GJ
Cancer Med; 2021 Apr; 10(8):2579-2589. PubMed ID: 33314716
[TBL] [Abstract][Full Text] [Related]
40. Radiomics-based tumor phenotype determination based on medical imaging and tumor microenvironment in a preclinical setting.
Müller J; Leger S; Zwanenburg A; Suckert T; Lühr A; Beyreuther E; von Neubeck C; Krause M; Löck S; Dietrich A; Bütof R
Radiother Oncol; 2022 Apr; 169():96-104. PubMed ID: 35192909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
